Last reviewed · How we verify

NCT06867887: DRIVE-ID

Non-invasive Detection of Driveline Infections in Patients with a Left Ventricular Assist Device

ENROLLING BY INVITATION Last updated 10 March 2025
What this trial tests

trial in LVAD (Left Ventricular Assist Device) Driveline Infection in 70 participants. Enrolling by invitation.

Timeline
12 February 2024
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorErasmus Medical Center
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment70
Start date12 February 2024
Primary completion31 December 2026
Estimated completion31 December 2026
Sites1 location across Netherlands

Conditions studied

Sponsor

Erasmus Medical Center

Who can join

Adults 16 to 99, any sex, with LVAD (Left Ventricular Assist Device) Driveline Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this single center observational study is to determine the feasibility of using non-invasive imaging methods, including smartphone photography and infrared thermography, for detecting of DLIs in LVAD patients in terms of severity, extent and natural healing process.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Erasmus Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06867887.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing